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Evaluation of Percutaneous Laser Myocardial Revascularization in
Chinese Patients with Refractory Angina Pectoris
CAIYI LU, XUAN WEI, CONGCHUN HUANG, HUILAN LUO, SHUSEN MAO
From Air Force General Hospital, Beijing 100036, PR China
LU ET AL.: Evaluation of Percutaneous Laser Myocardial Revascularization in Chinese Patients with Refractory
Angina Pectoris. The study aims to evaluate the feasibility and effect of percutaneous laser myocardial
revascularization (PMR) in patients with refractory class III-IV angina. Patients were selected by: (1) angina class
≥III; (2) unsuitable to CABG and PTCA; (3) LVEF ≥30%; (4) absence of myocardial infarction in 6 months; (5)
maximum diastolic wall thickness of left ventricle (LV) ≥8 mm in echocardiography. Eclipse Holmium laser generator
and catheter were used. Eighteen patients (17 male and 1 female) with age of 63.3±7.5 years and a history of angina
for 9.6±7.0 years were studied. They were refractory to 5.8±0.7 antianginal drugs. The angina class was IV in 11
patients and III in 9 patients. Maximum diastolic LV wall thickness was 10.2±0.8 mm. LVEF was 41.2±6.2%. Eleven
and 9 patients had triple vessel and double vessel diffuse disease, respectively. A mean of 19.7±6.3 endomyocardial
channels were made. Procedure time was 78.2±12.5 minutes and radiation time 24.3±7.4 minutes. There were no
complications. During the follow-up of 18.7±1.6 months, angina class decreased from 3.8±0.7 to 2.1±0.8 (P<0.05).
Ischemia in SPECT was significantly improved. PMR using Eclipse Holmium laser generator and catheter is safe in
Chinese patients. This results suggest that patients with refractory class III or IV angina could be controlled by
conjunctive use of PMR and regular antiangina drugs. (J HK Coll Cardiol 2000;9:3-8)
Angina pectoris, Holmium laser, myocardial revascularization
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Introduction
The principle of percutaneous laser
endomyocardial revascularization (PMR) is to make
endomyocardial channels in the ischemic left ventricular
walls by translating laser energy via a steerable optic
fiber catheter. From these channels, new capillary
network is reconstructed by angiogenesis development.
The channels are 6 mm in depth and 2 mm in diameter
and are apart from each other by 10 mm. Unlike
angioplasty (PTCA) or coronary bypass (CABG), PMR
is not limited by the characteristic and degree of
coronary vessel lesions, and is suitable to all kinds of
end-stage ischemic heart disease patients who cannot
be revascularized. Therefore, PMR will be a very
important supplement to PTCA/STENT and CABG.1-3
In order to evaluate the feasibility and safety of PMR
in the treatment of Chinese patients with ischemic heart
disease, we analysed the clinical and follow-up date of
18 patients who received PMR procedures in our center
in the recent 2 years.

Material and Methods
Patient Selection
Patient selection has been described in previous
publications.1-5 The 18 cases were selected by the criteria
of: (1) angina pectoris of class III-IV (Canadian Heart
Association Class), 6 (2) refractory to more than 4
antianginal drugs, (3) left ventricular ejection fraction
(LVEF) on echocardiography ≥30%, (4) absence of
acute myocardial infarction in the recent 6 months, (5)
multi coronary vessel diffuse lesions in paroxysmal and
distal parts on coronary angiography, (6) cardiac
ischemia confirmed by treadmill test and/or single
positron emmission computerised tomography
(SPECT), (7) the thickness of target left ventricular wall
in maximum diastolic period on echo ≥8 mm, and (8)
without catheter interventional complications.

(4) synchronization with ECG R wave and adjustable
delay triggered window, (5) Holmium: YAG laser, (6)
usable for both PMR and transmyocardial laser
revascularization. The laser catheter (PMRL-1, Eclipse
Corp., Figure 1) was 110 cm long, comprised of a 9F
XL2 guiding catheter (100 cm) and a 5F L1 laser catheter
(the inner laser fiber, 500 cm). At the tip of the laser
catheter, there is a mirror with a dimension of 1.75 mm
and 4 limiting petals mounted on it.

Procedure
A 9.5F artery sheath was introduced into right
femoral artery by Seldinger technique. Ten thousand
units of heparin was given via the sheath. The LV was
entered with a 6F pigtail catheter, through which a 9F
long sheath was reel rolled into LV. A LV angiogram
was performed with biplane DSA during quiet
breathing. The maximum diastolic LV imaging was
fixed and major LV landmarks were marked on the
video screens. Then the pigtail was withdrawn, and the
laser catheter advanced. The laser generator was
controlled at following parameters: 2 pulses per burst,
2J per pulse, synchronization window lasted 30 ms and
located before the first third of T wave ascending limb.
Delivered energy was calibrated before washing the
catheter system.
The following steps was adapted to make
endomyocardial channels in targeted ischemic LV walls.
Coronary and LV angiograms and echo results were
reviewed to confirm the targeted LV wall. The LV wall
was divided into anterior, lateral, inferior, septal and
blunt apical. The 9F sheath was then directed to the
targeted wall. By the continuous flushing of pressurised
normal saline, the laser catheter and its outer sheath

Equipment
MLAS-1 Holmium: YAG laser generator (Eclipse
Corp., San Francisco, CA, USA) was used. The machine
has the parameters of: (1) wavelength 2100 nm,
continuous adjustable energy from 1 to 6W, (2) pulse
width 200 µ, 2J per pulse and 1-3 pulse delivered per
burst, (3) automatic active energy calibration system,
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Figure 1. PMRL-1 laser catheter system (Eclipse Corp.),
including a XL2 guiding catheter and a L1 fiber catheter.
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were introduced into the LV chamber. The radiopaque
mark at the tip of the laser catheter enabled the operator
to visualize the catheter at the tip of the 9F sheath. The
laser catheter was then advanced until its tip was in
contact with the endomyocardium perpendicularly
(Figure 2); and a laser application was made. The
created channel was marked on the biplane video
screens to ensure the channels were evenly distributed
and to avoid two channels were made at the same point

(Figure 3). The laser catheter was then withdrawn and
the process repeated, until all targeted LV walls were
revascularized. During above procedure, ECG, arterial
pressure and the fluoroscopic heart movement were
monitored.

(A)

(B)

Follow Up
The following parameters were assessed during
follow-up: (1) Angina class, (2) standard 12 lead ECG,

Figure 2. Laser channels were marked on the right anterior oblique 30º(A) and left anterior oblique 45º (B) fluoroscopic screens
of left ventricular angiogram.
(A)

(B)

Figure 3. When perpendicularly pointed to the ventricular endocardium, the tip mark of the laser catheter could be visualized
as a filled rectangle on right anterior oblique 30º (A) and an open circle on left anterior oblique 45º (B), respectively.
5
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(3) treadmill test, (4) echocardiography, (5) SPECT, (6)
cardiac enzymes, (7) LV late potential, and (8) Holter
monitoring.

Statistic Analysis
Categoric data were expressed in percent and
value data in mean ± standard division (M±SD).
Student t test or χ2 test was used to analyse the data
and a P<0.05 was considered to be statistically
significant.

maximum diastolic LV wall thickness was 10.2±
0.8 (9-14) mm with regional motion amplitude of 7.4±
0.7 (5-9) mm. On coronary angiogram, fourteen patients
(78.6%) showed triple vessel disease and 4 patients
(21.4%) had double vessel disease. The LVEF was
43.5±3.7 (42-58)%.

PMR Procedure Data (Table 1)
A mean of 19.7±6.3 (9-30) laser channels were
made on 3±0.9 (2-4) LV walls. A mean of 70.3±11.5
(38-106) laser pulses and 137.9±20.4 (74-210) J were
delivered.

Results
Complications
Patient Data
Eighteen patients (17 male and 1 female) with
age of 65.4±8.2 (51-78) years were studied. Their angina
history was 9.6±7.0 (1-42) years. Their angina class was
3.8±0.7 (class IV in 11 cases and III in 7 cases). They
were refractory to the combination of 4.8±1.7 (3-7) types
of antianginal agents. On SPECT, the ischemic LV walls
were demonstrated in anterior, lateral and inferior walls
(9 patients), anterior, lateral and septal walls (5 patients),
and anterior, lateral and blunt apical walls (4 patients).
All had normal cardiac enzyme, liver and kidney
function and negative LV late potential. On
echocardiography, all patients showed normal cardiac
chamber size without aneurysm and thrombus. The

During laser delivery, all patients did not
experience abnormal sensation. There were no
complications of cardiac perforation, aortic or mitral
valve damage. Ventricular premature contraction was
provoked in 14 (77.8%) patients and nonsustained
ventricular tachycardia was induced in 9 (50.0%) by
intracardiac laser catheter manipulation. Total procedure
time was 78.2±12.5 (48-126) minutes and X-ray
radiation time was 24.3±746 (12-36) minutes.

Early Observation after PMR Procedure
All patients showed normal cardiac enzyme at 6,
12 and 24 hours after PMR procedure. Seven patients
had ST segment resolution in ECG.

Table 1. Channel distribution, pulse and energy data of 18 patients receiving PMR
LV wall
single wall
anterior
lateral
inferior
septal
two walls
A and L
A and I
A and S
three walls
A, L and I
A, L and S
Total

n

laser channel

laser pulse

laser energy

18
14
7
6

11.7±5.1 (7-14)
10.4±2.5 (7-11)
7.8±3.2 (5-9)
8.1±1.8 (6-10)

47.5±9.8 (36-62)
37.0±7.5 (27-42)
31.2±3.5 (23-34)
30.1±4.5 (22-36)

93.6±23.5 (68-118)
69.5±11.9 (26-74)
41.6±7.4 (32-49)
64.1±9.4 (32-76)

18
7
6

18.5±3.5 (7-26)
14.4±4.6 (6-18)
13.8±2.6 (5-21)

66.7±9.1 (36-87)
49.6±9.1 (27-94)
53.2±11.2 (37-86)

119.3±16.3 (70-206)
109.7±13.2 (68-182)
110.2±16.3 (67-176)

7
6
14

17.7±3.4 (7-26)
16.2±3.4 (9-21)
17.6±4.3 (9-26)

68.3±8.3 (34-96)
66.2±7.4 (36-101)
68.3±9.5 (36-104)

138.7±14.6 (72-204)
129.3±16.5 (69-197)
136.4±17.2 (72-208)

Note: A: anterior wall, I: inferior wall, L: lateral wall, LV: left ventricle, S: septal wall
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Follow-up Results (Table 2)
The angina class of all patients was improved
significantly in the follow-up period of 8.7±1.6 (3.511.5) months. The mean reduction in angina class was
1.7±0.4 (1.5-3.5).

Discussion
In this study, we have reported the favorable
experience of PMR in 18 patients with angina who were
refractory to conventional therapy. To ensure safety of
the procedure, the following items should be noted
during PMR operation: (1) Measuring the actual
delivered laser energy to avoid possible abnormal
connection between the catheter fiber and the generator.
The latter can cause the delivered laser energy
abnormally high or low. High energy will lead to cardiac
perforation or damage the cardiac structure, whereas low
energy will decrease the PMR effect. (2) The maximum
number of laser channel for any ischemic LV wall was
limited by the potential complications such as cardiac
perforation, at present the channels for one LV wall is
limited under 12, nearly approaching the density of one
channel per cm2. (3) To prevent cardiac perforation, the
stiff sheath should be manipulated smoothly and without
any resistance in the LV chamber. Pushing forward and
pulling back the sheath as well as the fiber catheter
always under the direction of continuous fluoroscopy,
and biplane X-ray screens were used to locate and
mark the channels. Continuously monitoring
electrocardiogram, arterial pressure and cardiac
movement amplitude were useful. (4) During PMR,
arrhythmias could be provoked by the mechanical

stimulation of catheter manipulation and the delivery
of laser energy. The former could be decreased by the
use of softer or lower profile laser catheters,
individualizing the catheter type and size, adjusting the
catheter contact with the endomyocardium according
to the cardiac movement and ensuring a stable catheter
tip in the LV chamber. Arrhythmia induced during laser
delivery could be prevented simply by synchronizing
the laser energy delivery to the safe period of the cardiac
electric interval.

Conclusion
It is feasible and safe to conduct PMR by Eclipse
Holmium laser generator and catheter in Chinese
patients. PMR allows patient with refractory class III or
IV angina despite conventional treatment to be
controlled.
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